Introduction
Skeletal muscle provides an excellent target for the expression of recombinant genes as its structure and function are well understood. It represents 30-50% of total body mass and its easy accessibility lends itself well to the study of gene transfer techniques. A further advantageous characteristic is the post-mitotic state of mature myofibres, which may facilitate long-term persistence of episomal transgenes. This feature is especially relevant to liposome-mediated gene transfer where stable integration of a transgene into the host genome does not normally occur at a high frequency, so genetic material can be rapidly lost from transfected cells during repeated rounds of cell division. Gene transfer into muscle has been proposed for the treatment of inherited and acquired disorders both of muscle and nonmuscle tissues. For example, pre-clinical studies are currently underway to try and alleviate the symptoms in animal models of primary muscle myopathies such as Duchenne muscular dystrophy, using viral and nonviral techniques. 1 A second major therapeutic application is to utilise muscle tissues as an environment to express recombinant, nonmuscle proteins actively. This approach has been used as a DNA vaccination system against, for example, the hepatitis B virus, 2 and as a means to augment levels of serum proteins such as cytokines and lipoproteins. 3 High efficiency gene transfer into many eukaryotic tissues and cell types has previously been achieved using viral vectors. However, associated toxicity problems, biosafety issues and adverse immune responses have led to the development of a range of alternative, nonviral systems, where repeated administration is possible. 4 Some of the most promising results have come from the use of cationic lipids which are able to complex with nucleic acid to form a lipoplex and deliver genes to the nucleus via the cellular endocytosis pathway, without significant toxicity, immunology or germ cell localisation. [5] [6] [7] The process of lipoplex formation involves electrostatic interactions between the cationic lipid and anionic DNA, as opposed to traditional liposome technologies which result in encapsulation of DNA. 8 Since their introduction 10 years ago, 9 many cationic lipid formulations have been tested in a variety of in vitro situations and have often yielded highly efficient transfection, 10, 11 superior to that obtained with encapsulating liposomes. 12 However, studies administering lipoplexes to a range of tissues in vivo have led to mixed results. It seems that cationic lipids may be suited to certain tissue types such as lung or tumour [13] [14] [15] where clinical trials are now in progress. 16, 17 Muscle presents a special case, where direct injection of naked plasmid DNA has resulted in significant levels of expression. 18 By complexing the DNA with cationic lipid, it may be possible to produce a more efficient and reproducible system of gene transfer into muscle, perhaps by promoting an alternative route of uptake. The concept of using lipoplexes as a method of DNA vaccination via intramuscular injection has already been demonstrated. 19 As a prelude to direct in vivo gene transfer studies, we have compared the ability of two commercially available cationic lipids (Lipofectamine and DOSPER) to transfect C2C12 cells, a mouse muscle cell line in vitro. Two different reporter plasmids were utilised, first containing the 543 lacZ gene (pCMV␤), and second, the gene for green fluorescent protein (GFP; pUCUF2). Cultures were then assessed using histochemical staining or FACS analysis, respectively. Parameters were completely optimised in C2C12 cells, and then transfections into primary mouse myoblasts and myotubes were performed using these optimal conditions, as these are likely to represent a closer model of the in vivo situation. In addition, formulations suitable for in vivo injection were determined.
Results
To establish maximal DNA transfection efficiency using the cationic lipids, a range of parameters were optimised. The optimisation studies were all performed in cultured C2C12 cells using either the lacZ or GFP reporter genes in the plasmid expression vectors pCMV␤ and pUCUF2, respectively. Direct comparison of transfection with the two vectors showed no significant difference in the optimal conditions found, indicating that the nature of the plasmid used is largely irrelevant. All experiments were carried out in parallel for Lipofectamine and DOSPER and each condition was repeated in triplicate in independent cultures for statistical significance. Lipofectamine-mediated transfections were performed in serum-free medium, and DOSPER-mediated transfections in 5% FCS medium unless stated otherwise.
Lipid:DNA ratio of complex Lipoplex formation is dependent upon the charge ratio between the DNA and lipid. 8 Therefore, a range of weight to weight ratios was tested using the GFP reporter system and FACS analysis (Figure 1 ). Transfections were performed in serum-free medium with Lipofectamine and 5% FCS medium with DOSPER. Cells were counted by FACS analysis 24 h after transfection. This revealed that a DOSPER:DNA ratio of 2:1 and a Lipofectamine:DNA ratio of 7.5:1 led to maximal efficiency ( Figure  2 ). These are equivalent to charge ratios (positive:negative) of 2.73 and 11.2, respectively, showing that both lipoplexes have an overall positive charge (see Materials and methods). The amount of lipoplex required for maximal transfection efficiency was detected by fixing the weight:weight ratio and altering the amount of DNA and therefore also lipid added. For both Lipofectamineand DOSPER-mediated transfections in 35 mm dishes, 4 g of DNA led to maximal efficiencies (33% ± 5.74 and 23% ± 0.68 of gated cells, respectively). Increasing the amount of DNA further had no significant increase on efficiency ( Figure 2 ) and although a slight increase in cell toxicity was observed, cell survival remained high (results not shown). Full cell survival data are not shown for this set of experiments using the GFP reporter system, as FACS analysis proved to be a poor indicator of the true level of cell death following transfection, as discussed later. Therefore, a comparison with an alternative reporter system was made, transfection with pCMV␤ followed by X-gal histochemical staining for ␤-galactosidase activity. C2C12 myoblasts were transfected with pCMV␤ lipoplexes in the optimal ratios described above. Efficiencies were expressed as the percentage of positive cells in relation to the total surviving cell number at the time of analysis, and values of 41.3% ± 1.3 and 35.9% ± 4.0 for Lipofectamine and DOSPER, respectively, were obtained. As this represents a more accurate measure of transfection efficiency, all further studies were performed using the lacZ reporter system and lipoplexes formed in these established optimal lipid:DNA ratios.
Lipoplexes formed in these optimal ratios were additionally observed by negative staining TEM. Aggregates of multilamellar vesicles were seen for both Lipofectamine-DNA and DOSPER-DNA lipoplexes ( Figure  3 ). The size of these complexes was extremely varied, with Lipofectamine-DNA complexes being significantly bigger than DOSPER-DNA complexes (100-830 nm and 125-350 nm, respectively; P Ͻ 0.05). Discrete lipid vesicles approximately 100 nm in diameter were observed in controls with lipid alone.
Stability of expression
The stability of transgene expression was studied in a set of transfections in which wells were fixed and stained at varying time-points (20-72 h) following transfection. Maximal expression (25.6% ± 2.94 and 17.5% ± 2.32 for Lipofectamine and DOSPER, respectively; means ± s.d.) was achieved by 18 h and remained at an equivalent level up to 72 h (results not shown). These experiments in C2C12 myoblasts could not be extended past 72 h as myoblast differentiation and fusion began to take place. In all further studies expression was analysed 24 h after transfection.
Time of incubation of complexes with cells
An incubation time of 6 h is recommended by the manufacturers for both DOSPER and Lipofectamine transfections. This was re-examined in the myoblast system to establish the effect of reduced incubation times on transfection efficiency and toxicity ( Figure 4 ). It was found that transfection efficiency increased up to 4 h (41.7% ± 3.5 for Lipofectamine and 37.0% ± 4.3 for DOSPER), and remained stable with longer incubation of the lipoplexes with the cells up to 6 h. Nevertheless, an incubation time of 2 h may be preferable as significant efficiencies of 30.5% ± 1.7 with Lipofectamine and 28.3% ± 2.4 with DOSPER were achieved, with the advantage of increased levels of cell survival (56% ± 8.7 and 45.3% ± 9.3 for Lipofectamine and DOSPER, respectively, at 2 h, as opposed to 17.7% ± 2.1 and 24.3% ± 4.6 at 4 h). As both Lipofectamine-and DOSPER-mediated transfections were performed in serum-free medium for this set of experiments, and control cells exposed to serum-free medium for 6 h showed notable levels of toxicity, the level of cell death perceived is not entirely due to the transfection reagent, but in part to the incubation in serum-free medium. Therefore it was necessary to study the exact effect of serum on transfection efficiency and cell survival.
Effect of serum on transfection
In an effort to eliminate the cell death resulting from incubation in serum-free medium, a comparison of transfections performed in serum-free 5% FCS and 10% FCS containing medium was made ( Figure 5 ). Lipoplexes were formed with 4 g DNA in a 7.5:1 or 2:1 ratio for Lipofectamine and DOSPER, respectively, and incubated with C2C12 myoblasts for 6 h. Lipofectamine had a significantly reduced transfection efficiency in 5% and 10% FCS DMEM, relative to serum-free medium, resulting in only 1.2% ± 0.9 and 0.5% ± 0.3 positive cells, respectively. Transfection with DOSPER was, however, less adversely affected by the presence of serum, as an efficiency of
Figure 1 Green fluorescent protein FACS analysis following transfection of C2C12 myoblasts with lipoplexes. Cells were initially evaluated by size (1) in order to select a region representing single cells. This gated region was further analysed for fluorescence. A negative control (cells transfected with lipid complexed with an irrelevant DNA (pCMV␤)) was used to set the position of quadrants separating GFP-positive cells (green; lower right), GFPnegative cells (nonfluorescent; lower left) and dead cells (red; upper left) (2). These quadrants were then applied to the analysis of experimental wells (3) and percentage cell number/ total cell number in gated region calculated for each quadrant. These procedures were followed for cells transfected with either Lipofectamine or DOSPER. (a) Transfection with Lipofectamine-pUCUF2 lipoplexes resulted in: GFP-positive cells (lower right), 37.19%, GFPnegative cells (lower left), 55.43% and dead cells (upper left), 7.10%. (b) Transfection with DOSPER-pUCUF2 lipoplexes resulted in: GFP-positive cells (lower right), 23.81%, GFP-negative cells (lower left), 68.09% and dead cells (upper left), 7.08%.
9.9% ± 1.9 was achieved in 5% FCS DMEM compared with 33.1% ± 3.6 positive cells in serum-free medium. The advantage of reduced toxicity was evident during these DOSPER-mediated transfections, with 83% ± 8.7 of cells surviving in the presence of serum, relative to 35% ± 4.2 in serum-free medium. Similar studies in the presence and absence of mouse serum led to even more pronounced differences. In serum-free medium, efficiencies of 42% ± 9.2 and 41.9% ± 2.1 were obtained for transfections with Lipofectamine and DOSPER, respectively. This compares with 0.9% ± 0.1 and 31.8% ± 3.2 in the presence of 10% mouse serum. It is important to note that the decrease in percentage efficiency seen in the presence of mouse serum or FCS, does not simply reflect an increase in cell survival, but the absolute number of positively transfected cells actually decreases.
Transfection of primary cultures and C2C12 myotubes
Primary mouse muscle cultures were transfected with Lipofectamine-DNA and DOSPER-DNA lipoplexes in serum-free medium using 4 g DNA in varying lipid:DNA ratios. Both lipids were able to mediate transfection, but at a lower level than achieved in the C2C12 cell line (Table 1) . Also, the significant variation noted in C2C12 cells between efficiencies resulting from transfections with different lipid:DNA ratios, was not clearly seen in primary cultures. Transfection of 5-day-old C2C12 myotubes proved to be inefficient, resulting in only a small number of positives per well. The total number of positive ␤-gal myotubes was marginally higher in DOSPER-transfected cultures than those transfected with Lipofectamine (results not shown).
Complex formation time and volume
One long-term aim of our work is to assess the ability of Lipofectamine-DNA and DOSPER-DNA lipoplexes at mediating transfection of muscle cells following direct intramuscular delivery in mice. When performing intramuscular injections in the mouse, a physical limit on injection volume per muscle exists. Therefore we examined whether it was possible to produce the lipoplex in a concentrated form, in order to inject a larger amount of DNA. Experiments were performed on C2C12 myoblasts, and lipoplexes were formed using fixed amounts of DNA (pCMV␤) and lipid in varying volumes of HBS ( Figure  6 ). Equal volumes of lipid and DNA were mixed to give total volumes varying from 10 to 120 l. Transfections were performed in serum-free medium using 4 g pCMV␤ and 30 g Lipofectamine, or in 5% FCS medium using 2 g pCMV␤ and 4 g DOSPER. In the case of Lipofectamine-DNA lipoplexes, the volume of formation had little effect as resultant efficiencies were similar regardless of whether a volume of 20 l or 120 l was adopted. However, DOSPER-DNA lipoplexes formed more efficiently and led to higher transfection efficiencies if a volume of 10 l was used as opposed to 100 l (13.8% ± 0.6 and 6.9% ± 1.4, respectively; P Ͻ 0.01). In both cases these results are beneficial for in vivo experiments as a higher dose of lipoplex can be administered to each muscle. It is important to note that the transfection efficiencies obtained with DOSPER-DNA lipoplexes in this particular set of studies is lower than previously seen. This is due to less DNA being used (2 g as opposed to 4 g), and the transfections being performed in the presence of 5% serum which has a slight inhibitory effect.
In order to ensure consistency during the injection procedure, the stability of lipoplexes before addition to the cells was investigated. Lipoplexes were formed in HBS and held at room temperature for 15 min, 30 min and 1 h. This revealed that DOSPER-DNA complexes were less active at certain concentrations if left to form for longer than the 15 min suggested by the manufacturers. The resultant transfection efficiency was reduced to as little as 2.8% ± 1.0 if complexes were formed in a total volume of 60 l over 1 h. Lipofectamine complexes, however, retained their activity relative to DOSPER complexes and mediated transfection of similar efficiencies if formed over 15 min or 1 h (Figure 6 ).
Discussion
The efficacy of Lipofectamine as a mediator of transfection in vitro has been extensively documented. 20, 21 However, reports of associated toxicity 22 have led to the development of newer alternative cationic lipids. One such novel formulation is DOSPER, and here we describe a detailed comparison of Lipofectamine and DOSPER in their ability to transfect C2C12 and primary mouse muscle cells in culture. These studies have highlighted several differences between the two lipids, which have implications for the design of future large-scale transfections and in vivo applications.
While there has been much debate concerning the mechanism of uptake of lipoplexes into the cell, it is now accepted that endocytosis is the main process involved. 5 However, the initial interaction between lipoplex and cell membrane is electrostatic, 8 hence the overall charge of the lipoplex is critical. For this reason, the first parameter to be optimised was the weight:weight ratio of positively charged lipid to negatively charged DNA. With both lipids tested, the optimal lipid:DNA ratio resulted in lipoplexes that bear an overall positive charge, enabling association with the negative charge of the cell membrane. Increasing the ratio further, by addition of more lipid, led to a decrease in resultant transfection efficiency, possibly due to the toxicity of excess lipid to cells. The two different plasmids used, pCMV␤ and pUCUF2, gave the same optimal lipid:DNA ratios, as a given quantity of DNA, irrelevant of sequence, will have the same charge. Electron micrographs of lipoplexes formed in these optimal ratios show populations of lipid-DNA aggregates with significant variation in size. We found DOSPER lipoplexes to be generally smaller than Lipofectamine lipoplexes, which may be significant during cell uptake and in future in vivo administrations where large lipoplexes may be physically restricted.
Toxicity parameters have as much value as transfection efficiency when assessing the effectiveness of a lipid in transfecting maximum numbers of cells. Toxicity data also provide valuable information required for the design of improved lipid formulations. Use of the GFP reporter system 23 allowed rapid analysis of transfection efficiency as no additional histochemical staining was required. However, although this method of FACS analysis gave quantitative data for live, positive cells, it proved to be a poor indicator of the true level of toxicity when compared with direct microscopic examination. With FACS analysis, estimates of toxicity are inaccurate, as only the cells surviving the transfection procedure and trypsinisation are measured. Those cells which detach during transfection are immediately discarded when the medium containing the lipoplexes is replaced. It was found that microscopic observation of the cultures provided a better measurement of toxicity as the number of cells remaining on a treated well in proportion to the number of cells on an untreated well can be calculated. In this way, a realistic estimate of percentage cell survival enabled true comparisons to be made.
Our data revealed that there appear to be two aspects to the problem of cell survival, the toxicity of the lipoplexes themselves and the adverse effect of the cells being exposed for various periods of time to serum-free medium. We have demonstrated that treatment with complexes containing Lipofectamine or DOSPER in serum-free conditions is equally toxic to cells. When the effect of serum deprivation was eliminated by transfecting cells in 10% FCS DMEM, only low levels of cell death were observed, at similar levels, for both Lipofectamine and DOSPER. Thus it seems that the majority of cell death observed is due to the absence of serum from the medium which may affect the toxicity of transfection in a number of ways. First, we found that cells incubated in serum-free medium containing no transfection reagents showed significant levels of cell death as a result of them being deprived of growth factors vital for their survival. Second, charge neutralisation of lipoplexes and reduced cellular uptake in the presence of serum, may also result in decreased apparent cell toxicity. Therefore it was desirable to attempt to reduce the length of time in which cells were subjected to lipoplexes in serum-free medium. We showed that the incubation time for both Lipofectamineand DOSPER-mediated transfections could be reduced to 2 h, as opposed to the 6 h recommended by the manufacturers. This led to increased levels of cell survival, with only minimal loss of transfection efficiency.
In the light of these data, the ideal situation would be to avoid serum-free transfection conditions altogether. Studies in serum-containing medium revealed a major difference between Lipofectamine and DOSPER.
DOSPER was able to mediate transfection efficiently in the presence of 5% serum, and was able to transfect cells at a low level even in the presence of 10% serum. This contrasted with Lipofectamine which, unless used in serum-free medium, was unable to induce any gene transfer. This phenomenon of inactivation in the presence of serum has previously been reported for other cationic lipids 24 and is likely to be due to the neutralising effect of anionic components of the serum. Although Lipofectamine promotes transfection at a higher efficiency relative to DOSPER in serum-free medium, this can be considered an artificial environment. Transfection efficiencies in the presence of serum are more likely to mimic the in vivo situation. In these circumstances, DOSPER proved to be the superior transfection reagent, so should be pursued as a potential mediator of gene transfer in vivo. Importantly, similar results were obtained following transfection in the presence and absence of mouse serum (results not shown).
As in vivo gene transfer conditions are generally more limited than in cell culture, other relevant parameters were examined. Lipoplex formation volumes and formation times are two such parameters requiring optimisation before intramuscular administration, where it is desirable to produce the lipoplex in a more concentrated form without loss of function. In a series of transfections we varied the volume during complex formation. We found that smaller volumes for DOSPER-DNA complexes promoted transfection at a significantly higher efficiency than that with larger volumes. However, vari- ation of volume during the formation of Lipofectamine-DNA complexes had no notable effect on transfection efficiency. Our studies, in agreement with work published by Staggs et al, 25 suggested that it is only the concentration during lipoplex formation which is critical, and the final concentration of the mixture presented to the cells is less important. When lipoplex formed in a fixed volume was added to cells in 1 ml, 2 ml, 3 ml or 4 ml medium, there was little resultant variation in transfection efficiency (results not shown).
Varying the time of complex formation revealed another main difference between Lipofectamine and DOSPER. At certain concentrations, DOSPER-DNA complexes lost some of their ability to transfect C2C12 cells if left to form for longer than 15 min, whereas Lipofectamine-DNA complexes in general could be left without significant effect for up to 1 h. One explanation is that increased complex aggregation with time occurs in complexes containing DOSPER, to a greater extent than in those containing Lipofectamine, and that this increased clumping leads to a decrease in transfection efficiency. Further EM studies observing lipoplex sizes, may serve to resolve these questions.
As observed previously, 21, 22 cultures of C2C12 cells left to fuse into myotubes before transfection proved to take up DNA at a much lower efficiency than in myoblasts. However, the use of lipid for ex vivo myoblast gene transfer, followed by transplantation into muscle would avoid this problem. 26 It is also possible to take advantage of the regenerative capacity of muscle, where new populations of myoblasts, termed satellite cells, could be transfected. This process of regeneration occurs naturally in some muscle disorders such as the muscular dystrophies. Transfection of primary mouse muscle cultures also yielded lower efficiencies, with no notable difference between Lipofectamine and DOSPER in serum-free medium as observed in C2C12 myoblasts. Unlike in C2C12 cells, variation of lipid:DNA ratios revealed no clear optimal ratio, but a more extensive programme of optimisation experiments in primary cultures is now in progress. This lack of variation is possibly due to the low efficiencies seen.
In conclusion, muscle is an attractive gene therapy target tissue for expression of both endogenous and secreted products. Transgenic myofibres exhibit high stability characteristics and long-term persistence of gene expression. Gene transfer can be mediated via ex vivo or in vivo transfection of proliferating myoblasts which fuse into existing myofibres. Our studies have served to highlight the similarities and differences in the ability of Lipofectamine, and the less well tested lipid, DOSPER, to transfect muscle myoblasts in vitro. We have demonstrated them both to be capable of efficiently transfecting cultured myoblasts in serum-free medium. However, Lipofectamine is dramatically inhibited by the presence of serum, unlike DOSPER which is able to continue to mediate transfection of a high efficiency. DOSPER may therefore prove to be better suited to gene transfer in vivo, and because the requirement for serum-free medium can be avoided, large-scale transfections in vitro may be performed with reduced levels of cell death. In addition, in combination with virus vector or vector components, application to post-mitotic target cells such as myofibres may be feasible. 27 
Materials and methods
Cell culture C2C12 cells are an adherent cell line initially cloned from mouse skeletal muscle. 28 They were grown at 37°C and 8% CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) foetal calf serum (FCS) and 2 mm glutamine. For efficient formation of myotubes, culture medium was switched to 5% heat inactivated horse serum to promote cell differentiation and fusion. Primary cell cultures were prepared by dissociation of hind and fore limb muscle tissues of new born C57/B10 mice as previously described. 29 These cells were plated in 15% FCS DMEM plus 2 mm glutamine, on 35 mm dishes (Nunclon, from Life Technologies, Paisley, UK) that had been pre-coated in Matrigel (Becton Dickinson, Oxford, UK). Cultures were grown to 50-80% confluence and transfected without further passage.
Plasmid constructs
The pCMV␤ plasmid (Clontech, Palo Alto, California, USA) is a 7.2 kb eukaryotic expression construct containing a lacZ gene and a CMV promoter. The pUCUF2 plas- Lipoplexes were formed using 4 g DNA in varying lipid:DNA ratios in optimal complex formation volumes, and efficiencies expressed as positive cell number/total cell number on well.
mid is a 4.4 kb eukaryotic construct containing the GFP gene under the action of a CMV early promoter. This plasmid was constructed by inserting the GFP gene from pTRUF2 30 into pUC18. The GFP gene is gfph2 which is a humanised version with a further ser-thr(65) mutation, shifting the excitation peak to a higher wavelength of 490 nm. 31 Cationic lipid formulations Both lipids used in these studies are commercially available. Lipofectamine (Life Technologies) is a 3:1 (wt:wt) formulation of the polycationic lipid 2,3-dioleoyloxy-N-(2(sperminecarboxamido)ethyl)-N,N-dimethyl-1-propanaminium trifluoroacetate (DOSPA) and the neutral lipid dioleoyl phosphatidylethanolamine (DOPE) in membrane filtered water; stock concentration 2 g/l. DOSPER (Boehringer Mannheim, Mannheim, Germany) is a polycationic lipid (1,3-dioleoyloxy-2-(6-carboxyspermyl)-propylamide) without any neutral lipid in 50 mm MES buffer, pH 5.6; stock concentration 0.5 g/l. All stocks were stored at 4°C. ) of a six-well plate (Nunclon) in DMEM plus 10% FCS. Transfections were performed after an overnight incubation. The following describes a typical example of lipoplex formation, although volumes and amounts used were varied. DNA (usually 4 g) was diluted in sterile HEPES buffered saline (20 mm Hepes, 150 mm NaCl, pH 7.4) (HBS) to give a total volume of 50 l. The required amount of stock lipid for a specific lipid:DNA ratio, was also diluted in HBS to give a final volume of 50 l. The lipid was then added to the DNA and mixed by gentle pipetting. With Lipofectamine transfections, the medium was removed from the wells and replaced with 2 ml serum-free DMEM for the duration of the transfection. With DOSPER transfections, DMEM containing 5% FCS was used in place of the serum-free medium, unless otherwise stated. Following a 15 min incubation at room temperature, the 100 l of lipoplex formed was added directly into the wells. Negative controls for each experiment consisted of untreated cultures, or cultures treated with DNA or lipid only. For FACS analysis of pUCUF2 transfections, the additional control of cultures transfected with lipid complexed with an irrelevant DNA (pCMVCAT) was necessary. After a standard incubation time of 6 h, the medium containing the lipoplexes was removed and replaced with 2 ml DMEM plus 10% FCS, and expression analysed after 24 h unless otherwise stated.
FACS analysis and fluorescence microscopy
Analyses were performed 24-48 h after transfection of cultures. Medium containing any dead or detached cells was removed and retained. Adherent cells were released from the dish using 0.1% (w/v) trypsin in PBS, pooled with the medium, spun and resuspended in 1 ml medium. These cells were stored on ice to prevent clumping. Immediately before measurement, 1 l of propidium iodide was added to mark the dead cells fluorescently. In the FACS, cells were initially analysed by size, and a region representing single cells gated off, thereby eliminating clumps and cell debris from further analysis. The gated region was then selected and analysed for green and red fluorescence. Quadrants were set using the irrel-evant DNA plus lipid control, so experimental samples could be measured and separated into dead cells (red), live positive cells (green) and live negative cells (nonfluorescent) (Figure 1 ). Efficiency of transfection was expressed as the percentage of positive cells over total cells in the gated region. Where appropriate, cultures were visualised by fluorescence microscopy.
Calculation of lipid:DNA charge ratio
The charge ratio of the lipoplex was calculated by positive charge equivalents of the cationic component/negative charge equivalents of the nucleic acid component. 32 Each nucleotide monomer of DNA carries one negative charge and has an average molecular weight of 330. Both DOSPER and DOSPA (cationic lipid present in Lipofectamine) have a maximum of four positive charges per molecule, and molecular weights of 968 and 884, respectively.
Electron microscopy
Lipoplexes were formed using either 5 g of Lipofectamine and 0.66 g DNA, or 5 g DOSPER and 2.5 g DNA, in a total volume of 50 l HBS. This solution was applied to formvar coated copper grids and left for 2 min, before drying with filter paper. The adsorbed samples were then negatively stained for 2 min using a 1% ammonium molybdate solution. Micrographs were taken on a TEM Hitachi H600 (75 kV) (Wokingham, UK).
␤-Galactosidase histochemistry Cells were washed once in 100 mm phosphate buffer (PB, pH 7) and then fixed in 0.5% glutaraldehyde (Agar Scientific, Stansted, UK) in PB containing 1 mm MgCl 2 . Cells were then given three 10-min washes in Nonidet P-40 solution (1 mm MgCl 2 , 0.02% Nonidet P-40 (Merck, Leicester, UK) in PB) to permeabilise the cells further. The staining procedure was performed overnight at 37°C using 1 mm MgCl 2 , 0.15 mm NaCl, 33 mm K 4 Fe(CN) 6 , 33 mm K 3 Fe(CN) 6 , and 0.1% 5-bromochloro-3-indolyl-␤-d-galactopyranoside (X-gal; Life Technologies) in PB. Transfection efficiency and toxicity were then assessed by counting ␤-gal-positive cells and total cell numbers in three random fields of vision per well, through an eye piece graticule. Efficiencies were expressed as the percentage of positive cells over the total cell number on an experimental well. Cell survival was expressed as the percentage of total cell number on the experimental well over the total cell number on an untreated control well.
Statistical analysis
All transfection efficiencies and cell survivals are presented as mean percentage ± standard deviation. Where appropriate, Student's t tests were performed, to give significance values.
